Vischer acted as legal counsel for Haya Therapeutics, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), on the closing of its CHF 18 million seed round. The financing was led
Tags :Adrian Briner
The team consists of Christian Wyss (Partner, Corporate / M&A), Sebastian Flückiger (Associate, Corporate / M&A), and Adrian Briner (Associate, Tax).
The team included Matthias Staehelin (Partner, Corporate - pictured), Sebastian Flückiger (Associate, Corporate), Nadia Tarolli (Partner, Tax) and Adrian Briner (Senior Associate, Tax).